In cancer, TXNIP was initially considered a tumor suppressor, this being notably supported by the observation that TXNIP-deficient mice exhibit a 40% higher incidence of spontaneously developing hepatocellular carcinoma (9, 15). The gene discussed is TXNIP; the disease is neoplasm.